A forum for researchers, students and applicants in the field of cyclodextrin technology
— Approval Based on Phase 3 Data Showing Veklury Significantly Reduced Risk of Hospitalization By 87% Compared with Placebo —
Gilead has conducted an analysis of genetic information currently available for the Omicron variant and found no additional prevalent mutations
In a recently published study intermolecular interactions of remdesivir and various cyclodextrin derivatives were characterized by extensive NMR spectroscopy. The
Efcacious therapeutics for Ebola virus disease are in great demand. Ebola virus infections mediated by mucosal exposure, and aerosolization in
Jubilant Pharmova subsidiary Jubilant Pharma has concluded safety and pharmacokinetic/absorption studies of a new oral formulation of remdesivir in animals
The development of remdesivir has been a breakthrough for COVID-19 treatment. It has been approved in about 50 countries since
The aim of the study was evaluation of remdesivir, an RNA polymerase inhibitor, for effectiveness in adults with COVID-19. 52
This review discusses the basic properties of the different cyclodextrin derivatives, their potential in antiviral formulations, and the prevention and
The antiviral potential of the antifungal itraconazole and the antidepressant fluoxetine was tested on the production of infectious SARS-CoV-2 particles
The scientists from Netherland reported 3 cases on remdesivir infiltration in patients with Covid-19. In the first case, a 91-year-old
